Results for: Activist Investing

Elliott Investment Management made significant portfolio changes in the third quarter, focusing on travel and lodging, with notable investments in airlines and hotel companies. The firm also increased positions in tech giants and made strategic adjustments in other sectors. This article analyzes Elliott’s key moves and provides insights into the firm’s investment strategy.

Pfizer, facing declining share price and strategic criticism, is under pressure from activist investor Starboard Value, which has acquired a $1 billion stake in the company. Starboard is pushing for a more focused development strategy and deeper cost cuts, aiming to turn around the pharmaceutical giant’s fortunes.